Cannabichromene (CBC) is a psychoactive non-psychotropic phytocannabinoid. It was discovered in 1964 and is the decarboxylated form of CBCa found in heated juvenile cannabis. As the plant matures, the CBC levels lower, but GW Pharmaceutical was able to develop a mutated Cannabis sativa variety that has difficulties producing THC and CBD, allowing the CBC to accumulate in higher amounts than naturally found. CBC binds to neither CB1 or CB2 receptors at standard doses, instead interacting with the capsaicin vanilloid receptor TRPV1 and the protein TRPA1. Interacting with these receptors means it can increase the levels of endocannabinoids, such as AEA and 2AG, by interfering with the natural process that degrades them. At much higher doses, those exceeding 100 mg, CBC has been shown to be a partial CB1 receptor agonist.
How CBC Assists
CBC in particular has been shown to assist with anxiety, OCD, stress, asthma, bacterial infections, bronchitis, depression, osteoporosis, skin disorder, acne, dermatitis, psoriasis, eczema and pain relief.
- Turner, CE. Elsohly, MA. Biological activity of cannabichromene, its homologs and isomers. Journal of Clinical Pharmacology. (1981)
- Ross, SA. ElSohly, MA. Sultana, GN. Mehmedic, Z. Hossain, CF. Chandra, S. Flavonoid glycosides and cannabinoids from the pollen of Cannabis sativa L. Phytochemical Analysis. (2005)
- DeLong, GT. Wolf, CE. Poklis, A. Lichtman, AH. Pharmacological Evaluation of the Natural Constituent of Cannabis Sativa, Cannabichromene and its Modulation by Δ9-Tetrahydrocannabinol. Drug and Alcohol Dependence. (2010)
- Izzo, AA. Capasso, R. Aviello, G. Borrelli, F. Romano, B. Piscitelli, F. Gallo, L. Capasso, F. Orlando, P. Marzo, V. Inhibitory effect of cannabichromene, a major non-psychotropic cannabinoid extracted from Cannabis sativa, on inflammation-induced hypermotility in mice. British Journal of Pharmacology. (2012)
- What is CBC (Cannabichromene)? Leaf Science. (2017)
- Miller, S. Understanding Cannabinoids – CBC, CBG, THCV, and CBDV. Green Flower. (2018)